| Oliver Lee Kesterson Iii, MD | |
|
1500 S Main St, Fort Worth, TX 76104-4917 | |
| (817) 702-3100 | |
| (817) 927-3603 |
| Full Name | Oliver Lee Kesterson Iii |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 43 Years |
| Location | 1500 S Main St, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306997515 | NPI | - | NPPES |
| 646000515 | Other | TX | TRICARE |
| 646000515 | Other | TRICARE | |
| OK04289020 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 18384 (Mississippi) | Secondary |
| 207T00000X | Neurological Surgery | F9664 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jps Health Network | Fort worth, TX | Hospital |
| Baylor Scott & White All Saints Medical Center Fort Worth | Fort worth, TX | Hospital |
| United Regional Health Care System | Wichita falls, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Acclaim Physician Group Inc | 4587963582 | 439 |
| Neurological Surgery Specialist Of North Texas Pllc | 3072853910 | 7 |
News Archive
A new research hub is set to transform Australia's medical technology sector by developing cost-competitive technologies for the rapid production of medical devices.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the signing of an agreement with Ono Pharmaceutical Co., Ltd. for the development and commercialization in Japan of KAI-4169, KAI's lead product candidate.
Health care spending is a large - and ever increasing - portion of government budgets. Improving its efficiency has therefore become critically important. In the first-ever study to estimate health spending efficiency by gender across 27 industrialized nations, researchers discovered significant disparities within countries, with stronger gains in life expectancy for men than for women in nearly every nation.
Eliza Corporation, the leading provider of integrated healthcare communication strategies, will be part of discussions about the future role of businesses in healthcare and how they are transforming and being transformed by Health 2.0.
A long-acting enzyme that rapidly and safely metabolizes cocaine in the blood stream is currently being investigated in animal models as a possible treatment for cocaine overdose.
› Verified 4 days ago
| Entity Name | Christus Trinity Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20031204001091 |
News Archive
A new research hub is set to transform Australia's medical technology sector by developing cost-competitive technologies for the rapid production of medical devices.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the signing of an agreement with Ono Pharmaceutical Co., Ltd. for the development and commercialization in Japan of KAI-4169, KAI's lead product candidate.
Health care spending is a large - and ever increasing - portion of government budgets. Improving its efficiency has therefore become critically important. In the first-ever study to estimate health spending efficiency by gender across 27 industrialized nations, researchers discovered significant disparities within countries, with stronger gains in life expectancy for men than for women in nearly every nation.
Eliza Corporation, the leading provider of integrated healthcare communication strategies, will be part of discussions about the future role of businesses in healthcare and how they are transforming and being transformed by Health 2.0.
A long-acting enzyme that rapidly and safely metabolizes cocaine in the blood stream is currently being investigated in animal models as a possible treatment for cocaine overdose.
› Verified 4 days ago
| Entity Name | Center For Neurological Disorders Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770509234 PECOS PAC ID: 7810886470 Enrollment ID: O20040318000170 |
News Archive
A new research hub is set to transform Australia's medical technology sector by developing cost-competitive technologies for the rapid production of medical devices.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the signing of an agreement with Ono Pharmaceutical Co., Ltd. for the development and commercialization in Japan of KAI-4169, KAI's lead product candidate.
Health care spending is a large - and ever increasing - portion of government budgets. Improving its efficiency has therefore become critically important. In the first-ever study to estimate health spending efficiency by gender across 27 industrialized nations, researchers discovered significant disparities within countries, with stronger gains in life expectancy for men than for women in nearly every nation.
Eliza Corporation, the leading provider of integrated healthcare communication strategies, will be part of discussions about the future role of businesses in healthcare and how they are transforming and being transformed by Health 2.0.
A long-acting enzyme that rapidly and safely metabolizes cocaine in the blood stream is currently being investigated in animal models as a possible treatment for cocaine overdose.
› Verified 4 days ago
| Entity Name | Acclaim Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780076562 PECOS PAC ID: 4587963582 Enrollment ID: O20160426000707 |
News Archive
A new research hub is set to transform Australia's medical technology sector by developing cost-competitive technologies for the rapid production of medical devices.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the signing of an agreement with Ono Pharmaceutical Co., Ltd. for the development and commercialization in Japan of KAI-4169, KAI's lead product candidate.
Health care spending is a large - and ever increasing - portion of government budgets. Improving its efficiency has therefore become critically important. In the first-ever study to estimate health spending efficiency by gender across 27 industrialized nations, researchers discovered significant disparities within countries, with stronger gains in life expectancy for men than for women in nearly every nation.
Eliza Corporation, the leading provider of integrated healthcare communication strategies, will be part of discussions about the future role of businesses in healthcare and how they are transforming and being transformed by Health 2.0.
A long-acting enzyme that rapidly and safely metabolizes cocaine in the blood stream is currently being investigated in animal models as a possible treatment for cocaine overdose.
› Verified 4 days ago
| Entity Name | Neurological Surgery Specialist Of North Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003389636 PECOS PAC ID: 3072853910 Enrollment ID: O20190318000091 |
News Archive
A new research hub is set to transform Australia's medical technology sector by developing cost-competitive technologies for the rapid production of medical devices.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the signing of an agreement with Ono Pharmaceutical Co., Ltd. for the development and commercialization in Japan of KAI-4169, KAI's lead product candidate.
Health care spending is a large - and ever increasing - portion of government budgets. Improving its efficiency has therefore become critically important. In the first-ever study to estimate health spending efficiency by gender across 27 industrialized nations, researchers discovered significant disparities within countries, with stronger gains in life expectancy for men than for women in nearly every nation.
Eliza Corporation, the leading provider of integrated healthcare communication strategies, will be part of discussions about the future role of businesses in healthcare and how they are transforming and being transformed by Health 2.0.
A long-acting enzyme that rapidly and safely metabolizes cocaine in the blood stream is currently being investigated in animal models as a possible treatment for cocaine overdose.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Oliver Lee Kesterson Iii, MD 1000 Houston Street, Suite 200, Fort Worth, TX 76102-6415 Ph: (817) 336-0551 | Oliver Lee Kesterson Iii, MD 1500 S Main St, Fort Worth, TX 76104-4917 Ph: (817) 702-3100 |
News Archive
A new research hub is set to transform Australia's medical technology sector by developing cost-competitive technologies for the rapid production of medical devices.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the signing of an agreement with Ono Pharmaceutical Co., Ltd. for the development and commercialization in Japan of KAI-4169, KAI's lead product candidate.
Health care spending is a large - and ever increasing - portion of government budgets. Improving its efficiency has therefore become critically important. In the first-ever study to estimate health spending efficiency by gender across 27 industrialized nations, researchers discovered significant disparities within countries, with stronger gains in life expectancy for men than for women in nearly every nation.
Eliza Corporation, the leading provider of integrated healthcare communication strategies, will be part of discussions about the future role of businesses in healthcare and how they are transforming and being transformed by Health 2.0.
A long-acting enzyme that rapidly and safely metabolizes cocaine in the blood stream is currently being investigated in animal models as a possible treatment for cocaine overdose.
› Verified 4 days ago
Anita Praful Bhansali, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 5th Ave Ste 500, Fort Worth, TX 76104 Phone: 817-250-4280 Fax: 817-250-4281 | |
Abdolreza Siadati, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Mistletoe Blvd, Suite 200, Fort Worth, TX 76104 Phone: 817-878-5333 Fax: 817-878-5334 | |
Gregory Alan Ward, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 909 9th Ave, Suite 201, Fort Worth, TX 76104 Phone: 817-870-5094 Fax: 817-885-7352 | |
Philip C Bechtel, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1900 Mistletoe Blvd, Suite 200, Fort Worth, TX 76104 Phone: 817-878-5333 Fax: 817-878-5334 | |
Yves J. Meyer, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1325 Pennsylvania Ave Ste 890, Fort Worth, TX 76104 Phone: 817-820-4280 Fax: 817-820-4281 | |
Dr. Atif Haque, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 8th Ave Ste A1131, Fort Worth, TX 76104 Phone: 817-912-9250 | |
Adrian Timothy Harvey, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 5th Ave Ste 500, Fort Worth, TX 76104 Phone: 817-250-4280 Fax: 817-250-4281 |